Dr. Blake Jacobs, MD
Critical Care Medicine (Critical Care Medicine (Internal Medicine) Physician)
- Medicare participating
At a glance
- Years since graduation
- 9
- In the NPI registry since
- 2017
- Medicare patients seen, 2024
- 85
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2017Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Critical Care Medicine (Internal Medicine) Physician primary
MO license 2025013440 -
Internal Medicine Physician
OK license 2025013440
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cox Medical Centers Springfield, MO
- Cox Medical Center Branson Branson, MO
- Citizens Memorial Hospital Bolivar, MO
Medical groups
- Lester E Cox Medical Centers (345 clinicians)
- Select Specialty Hospital Springfield Inc (7 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 85
- Services billed
- 184
- Patients’ average age
- 74
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 11 companies reported 14 payments worth $311 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $59.99 |
|---|---|
| Insmed, Inc. | $57.70 |
| Regeneron Healthcare Solutions, Inc. | $31.43 |
| Genzyme Corporation | $26.10 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.34 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.14 |
| Axsome Therapeutics, Inc. | $20.34 |
| Genentech USA, Inc. | $18.88 |
| Food and Beverage | $311 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.